BioTech
What to know about Alnylam’s upcoming readout on its heart drug
Next week, the biopharma world will see eagerly awaited results from a trial that could shape care for patients with an increasingly common heart condition
Elaine Chen, Andrew Joseph, and Adam Feuerstein
August 20, 2024